Immunohistochemical changes in prostate cancer after androgen deprivation therapy.
Bostwick, D G
Immunohistochemical changes in prostate cancer after androgen deprivation therapy. [electronic resource] - Molecular urology 2000 - 101-6;discussion 107 p. digital
Publication Type: Journal Article; Review
1091-5362
Adenocarcinoma--drug therapy
Androgen Antagonists--therapeutic use
Androgens--metabolism
Antineoplastic Agents, Hormonal--therapeutic use
Biomarkers, Tumor--metabolism
Humans
Immunohistochemistry
Male
Prognosis
Prostate--metabolism
Prostatic Neoplasms--drug therapy
Receptors, Androgen--metabolism
Treatment Outcome
Immunohistochemical changes in prostate cancer after androgen deprivation therapy. [electronic resource] - Molecular urology 2000 - 101-6;discussion 107 p. digital
Publication Type: Journal Article; Review
1091-5362
Adenocarcinoma--drug therapy
Androgen Antagonists--therapeutic use
Androgens--metabolism
Antineoplastic Agents, Hormonal--therapeutic use
Biomarkers, Tumor--metabolism
Humans
Immunohistochemistry
Male
Prognosis
Prostate--metabolism
Prostatic Neoplasms--drug therapy
Receptors, Androgen--metabolism
Treatment Outcome